2care4 Generics ApS: Financial statements 2022
CVR: 36960566
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
2care4 Generics ApS (CVR 36960566) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 75,691,000 and a net result of DKK 34,598,000 compared with DKK 29,082,540 the year before. That is an increase of 35.5% compared with the year before. Equity in the 2022 report amounted to DKK 74,230,000. The solvency ratio was 43.4%. The company had 12 employees in the financial year.
- Gross Profit
- DKK 75,691,000
- Profit/Loss
- DKK 34,598,000
- Equity
- DKK 74,230,000
- Total Assets
- DKK 170,991,000
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 75.7 mio. | 34.6 mio. | 74.2 mio. | 12 |
| 2021 | - | 55.9 mio. | 29.1 mio. | 44.6 mio. | 15 |
| 2020 | - | 32.9 mio. | 15.7 mio. | 15.5 mio. | 12 |
| 2019 | - | 8 mio. | -599 t. | -166 t. | 8 |
| 2018 | - | 3.3 mio. | -2.9 mio. | 434 t. | 7 |
Official annual report
Keep an eye on 2care4 Generics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
2care4 Generics ApS has published its annual report for 2021. Gross profit came to DKK 55,862,884, and the net result was DKK 29,082,540.
About 2care4 Generics ApS
2care4 Generics ApS is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Erik Sandberg. The board consists of Toke Værndal. The company is owned by 2care4 Group ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 52,415,000 and a net result of DKK 11,207,000 compared with DKK 17,193,000 the year before. Equity in the 2025 report amounted to DKK 49,944,000.